Core Viewpoint - The article highlights that Waigaoqiao Group's subsidiary, Shanghai Wailianfa Business Consulting Co., Ltd. (UDC), has successfully assisted InnoCare Pharma in its listing on the main board of the Hong Kong Stock Exchange, providing comprehensive consulting services for international development and cross-border investment financing [1] Group 1 - Waigaoqiao Group's financial consulting team played a crucial role in supporting InnoCare Pharma's listing [1] - The consulting services offered included full lifecycle support for international development and cross-border investment financing [1]